Cancer is a grievous disease whose treatment requires a more efficient, non-invasive
therapy, associated with minimal side effects. Gold nanoparticles possessing greatly …

The limitations of traditional cancer treatments are driving the creation and development of
new nanomedicines. At present, with the rapid increase of research on nanomedicine in the …

Simple Summary Since the targeting of a single pro-angiogenic factor fails to improve
oncological disease outcome, significant efforts have been made to identify new pro …

Breast cancer is one of the most frequently diagnosed cancers that is threatening women's
life. Current clinical treatment regimens for breast cancer often involve neoadjuvant and …

Next‐generation cancer treatments are expected not only to target cancer cells but also to
simultaneously train immune cells to combat cancer while modulating the immune …

Cancer immunotherapy is a groundbreaking strategy that has revolutionized the field of
oncology compared to other therapeutic strategies, such as surgery, chemotherapy, or …

Drug resistance is one of the most critical challenges in breast cancer (BC) treatment. The
occurrence and development of drug resistance are closely related to the tumor immune …

Macrophages within solid tumors and metastatic sites are heterogenous populations with
different developmental origins and substantially contribute to tumor progression. A number …

Ferroptosis is a new type of iron‐dependent programmed cell death characterized by
glutathione (GSH) depletion, selenoprotein glutathione peroxidase 4 (GPX4) inactivation …

Tumor-associated macrophages (TAMs) constitute 50–80% of stromal cells in most solid
tumors with high mortality and poor prognosis. Tumor-infiltrating dendritic cells (TIDCs) and …